Trial NCT01163201

View at ClinicalTrials.gov 
Org. Study IDs: 2009LS018
Secondary IDs: 0910M73595 MT2009-03

Last trial update was posted on 2017-12-02

MeSH Interventions

Cyclophosphamide Fludarabine

MeSH Conditions

Anemia, Refractory Anemia, Refractory, with Excess of Blasts Blast Crisis Burkitt Lymphoma Hematologic Neoplasms Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin Myeloproliferative Disorders Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Waldenstrom Macroglobulinemia

Other Conditions

Acute Lymphocytic Leukemia Acute Myeloid Leukemia Anemia, Refractory, With Excess of Blasts Burkitt's Lymphoma Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia in Blast Crisis Chronic Myeloproliferative Disease Follicular Lymphoma Hematologic Malignancy High Grade Non-Hodgkin's Lymphoma Large Cell Non-Hodgkin's Lymphoma Lymphoblastic Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Marginal Zone B-cell Lymphoma Prolymphocytic Lymphoma Small Lymphocytic Lymphoma

Stopping Reasons

Replaced by a new study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID